
ViGeneron and Biogen this week have announced a global collaboration and licensing agreement in which the partners will develop and commercialize gene therapy products based on adeno-associated virus (AAV) vectors that treat inherited eye disease.

ViGeneron and Biogen this week have announced a global collaboration and licensing agreement in which the partners will develop and commercialize gene therapy products based on adeno-associated virus (AAV) vectors that treat inherited eye disease.

Pandemic forces some to reconsider careers.

Roche’s faricimab is the focus of Yosemite and Rhine studies, which investigators say show it has the potential to offer lasting vision improvements for patients with diabetic macular edema.

A cluster of COVID-19 positive patients developed endophthalmitis, and investigators are searching for a link.

Minimally invasive conjunctival surgery option is an efficient procedure.

With intraoperative sustained release steroids, ophthalmologists can eliminate the gambles of patient adherence.

Nine pediatric patients with Leber congenital amaurosis show visual improvement in clinical trials.

Study supports preoperative ocular surface optimization with artificial tears.

All syringes used for intravitreal injections have pros and cons. Some recently marketed and forthcoming products are coming closer to meeting “ideal” criteria.

Change can prove to benefit individuals with diabetes, other comorbidities.

Safety protocols, creative solutions help physicians restore patient traffic to normal during the pandemic.

Procedure increases lens stability and improves visual acuity in patients.

A novel ocular corticosteroid is offering hope of quick results for patients.

The American Medical Association is encouraging women to become involved in policy making and educating health care leaders about the barriers women face in their career development.

Business strategy can prove beneficial for physicians at any stage of career.

The platform can autonomously diagnose vision defects and customize individual vision augmentation based on the user’s vision defects.

Chief Medical Editor Peter McDonnell, MD, explains why the individuals that we make an impact on as physicians often never forget us.

Approval of the Moderna vaccine gives the US a second option in the fight against COVID-19.

In light of an unprecedented year filled with technological advancements and pivots, Joshua Mali, MD, offers his top 5 predictions in ophthalmology for 2021.

Joshua Mali, MD, speaks on his annual top 5 predictions in ophthalmology for what's to come in 2021.

Novel OCT system with AI-based image analysis holds promise.

Frontline healthcare workers are among the first to receive the vaccine, and ophthalmologists and clinic staff could soon start receiving doses.

With several clinical trials underway, ocular therapy is seen as having potential in the treatment of a number of gene-related diseases.

In an open letter released Wednesday, the American Medical Association (AMA), American Hospital Association and the American Nurses Association are urging healthcare workers to get vaccinated against COVID-19.

Improvements gained prior to surgery can result in positive outcomes.

Check out the latest cartoon!


The effort is designed to empower patients, improve coordinated care, and reduce regulatory burdens.

Protocol T Extension Study details methods needed to maintain VA gains over time.

Interim data from a cross-sectional study raise concerns that repeated intravitreal injections of an anti-VEGF agent may be associated with a decline in cognitive health.